Documented security problems with compounded semaglutide incorporate dosing faults from incorrect compounding or mislabeling, contamination with microorganisms or other destructive substances for the duration of preparing, existence of impurities or unintended components, utilization of non-pharmaceutical quality Lively components from unregistered